Organization: Public Health Agency of Canada

Feds invest $887 million to ensure reliable vaccine supply for COVID-19, other pandemics

The federal government’s investment of $887 million make Canada self-sufficient in manufacturing vaccines against COVID-19 and future pandemics, say medical and other experts. Along with Canadian-led vaccine development, Ottawa is investing in a network of small-scale vaccine manufacturing facilities that together will be able to produce enough vaccine for Canada’s population during pandemics.

New research network at Queen’s University addresses growing prevalence of Lyme disease in Canada

The Canadian Institutes of Health Research (CIHR) and the Government of Canada are investing $4 million in a new research network focused on the prevention, control, diagnosis, and treatment of Lyme disease. Operated by Queen’s University, the Pan-Canadian Research Network on Lyme Disease aims to influence health outcomes, practice, programs and policy related to Lyme…

Innovative health solutions from SMEs needed under ISC program

New challenges in public health were recently announced under the Innovative Solutions Canada program, which aims to help small and mid-sized enterprises sell their innovative products and services to the government. Public Health Agency of Canada is looking for solutions for satellite images and communications platforms. The National Research Council of Canada needs suppliers for…

GRDI launches two new genomics projects

The federal Genomics Research and Development Initiative (GRDI) has announced $4 million for two new projects as part of a multi-departmental initiative to position themselves as key national and international players in the genomics field. The Antimicrobial Resistance project will explore how to make food production safer by reducing bacterial and microbial resistance. The EcoBiomics…